文献速递男科与性医学

富血小板血浆治疗勃起功能障碍安全有效吗?随机对照研究

Is Platelet Rich Plasma Safe and Effective in Treatment of Erectile Dysfunction? Randomized Controlled Study.
PubMed 文献 · Urology · 2023-02-01

这项安慰剂对照研究纳入100例轻中度勃起功能障碍患者,比较阴茎海绵体内注射富血小板血浆(PRP)与生理盐水的效果。PRP组在1个月和3个月随访时表现出显著改善,6个月时略有下降(P<.001),且在IIEF-EF、SEP Q2和Q3、 duplex参数及满意度方面优于安慰剂组。PRP组未报告斑块形成、皮下瘀斑或其他重大副作用。

要点

  • PRP组在1个月和3个月随访时改善显著,6个月时略有下降(P<.001)。
  • 1个月时PRP组76%达到IIEF-EF最小临床重要差异,盐水组为18%。
  • 未报告斑块形成、皮下瘀斑或其他重大副作用。

核心结论

  • PRP是改善轻中度勃起功能障碍的一种安全且有前景的方法。

研究设计与样本

  • 安慰剂对照研究,纳入100例轻中度勃起功能障碍病例,分为PRP组和安慰剂(生理盐水)组。
  • PRP组接受3次注射(每个海绵体3 mL),注射间隔15天;安慰剂(生理盐水)组接受6 mL生理盐水海绵体内注射。
  • 注射后随访持续6个月。

主要发现

  • 与安慰剂组相比,PRP组在1个月和3个月随访时表现出显著改善,6个月随访时略有下降(P<.001)。
  • 改善体现在duplex参数、国际勃起功能指数勃起功能域(IIEF-EF)、SEP Q2和Q3。
  • 治疗1个月随访时,PRP组76%患者IIEF-EF达到最小临床重要差异,盐水组为18%。
  • 治疗3个月随访时,PRP组72%患者达到最小临床重要差异,盐水组为16%;6个月随访时PRP组降至70%,盐水组为16%。
  • PRP组总体满意度和性交满意度高于安慰剂组,表现为IIEF评分Q6、Q7、Q8及IIEF评分Q13、Q14更高,最大改善报告于3个月随访时。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the safety and efficacy of platelet rich plasma (PRP) injections as a therapeutic modality for mild to moderate erectile dysfunction. METHODS: A placebo-controlled study of 100 cases with mild to moderate erectile dysfunction. Participants were allocated to 2 groups; the PRP group received 3 injections (3 mL each corpus) and the interval between injections was 15 days, while the Placebo (Saline) group received 6 mL saline injected intracavernous. Postinjection follow-up lasted 6 months. RESULTS: Compared to the placebo group, the PRP group demonstrated a significant improvement at the 1 and 3 months follow-up that slightly dropped at the 6 months follow-up (P <.001). The improvement was evident in the duplex parameters, International Index of Erectile Function Erectile Function (IIEF-EF), SEP Q2, and 3. At 1-month post-treatment follow-up (76%) patients in the PRP group had an improved IIEF-EF as they attained a minimal clinically important difference compared to (18%) in the saline group. At the 3-months post-treatment follow-up, (72%) patients achieved a minimal clinically important difference in the PRP group vs (16%) in saline group then dropped to (70%) in the PRP group vs (16%) in saline group at the 6-months post-treatment follow up. Patients' overall and intercourse satisfaction levels were higher in the PRP group than the placebo group as demonstrated with the higher IIEF score Q6, 7, 8, and IIEF score Q13, 14 respectively with the maximum improvement reported at the 3 months follow-up. No reports of plaque formation, subcutaneous bruising, or any other major side effects among participants. CONCLUSION: PRP is a safe and promising method for the improvement of mild to moderate erectile dysfunction.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Shaher H, Fathi A, Elbashir S, et al. Is Platelet Rich Plasma Safe and Effective in Treatment of Erectile Dysfunction? Randomized Controlled Study. Urology. 2023. PMID: 36736914. doi:10.1016/j.urology.2023.01.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。